Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.

@article{Robicsek2009TopicalTF,
  title={Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.},
  author={Ari A Robicsek and Jennifer L. Beaumont and Richard B. Thomson and Geetha Govindarajan and Lance R. Peterson},
  journal={Infection control and hospital epidemiology},
  year={2009},
  volume={30 7},
  pages={623-32}
}
OBJECTIVE We evaluated the usefulness of topical decolonization therapy for reducing the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection among MRSA-colonized inpatients. DESIGN Retrospective cohort study. SETTING AND INTERVENTION Three hospitals with universal surveillance for MRSA; at their physician's discretion, colonized patients could be treated with a 5-day course of nasal mupirocin calcium 2%, twice daily, plus chlorhexidine gluconate 4% every second day… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

Methicillin-resistant Staphylococcus aureus decolonization: "yes, we can," but will it help?

Infection control and hospital epidemiology • 2009
View 3 Excerpts
Highly Influenced

A wash twice a day keeps MRSA away?

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine • 2018

Risk Factors Associated with Mupirocin Resistance in Methicillin-Resistant Staphylococcus aureus

Aisling R. Caffreya, Brian J. Quilliamb, Kerry L. LaPlantea
2016
View 1 Excerpt

Similar Papers

Loading similar papers…